FDA Approved: LOKELMA — Supplemental Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved a supplemental application for LOKELMA (sodium zirconium cyclosilicate) from AstraZeneca, indicating an update or expansion to its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Lokelma (sodium zirconium cyclosilicate)

Snippet

SUPPL AP for LOKELMA (SODIUM ZIRCONIUM CYCLOSILICATE)